Plasmacytoid Dendritic Cell Neoplasm — Trials

Plasmacytoid Dendritic Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

41 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06006403	Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm	completed	Phase 1 / Phase 2	5	Chongqing Precision Biotech Co., LtdINDUSTRY	1	Aug 5, 2026	clinicaltrials
NCT02220985	Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD	completed	Phase 2	84	Fred Hutchinson Cancer CenterOTHER	1	Jun 1, 2026